Similar articles

• miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1.

  Zhan P, Shu X, Chen M, Sun L, Yu L, Liu J, Sun L, Yang Z, Ran Y. Zhan P, et al. Life Sci. 2021 Jul 1;276:119405. doi: 10.1016/j.lfs.2021.119405. Epub 2021 Mar 31. Life Sci. 2021. Retraction in: Life Sci. 2024 Sep 1;352:122888. doi: 10.1016/j.lfs.2024.122888. PMID: 33798550 Retracted.
• MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.

  Ma Z, Cai H, Zhang Y, Chang L, Cui Y. Ma Z, et al. Biochem Biophys Res Commun. 2017 Aug 19;490(2):309-316. doi: 10.1016/j.bbrc.2017.06.041. Epub 2017 Jun 12. Biochem Biophys Res Commun. 2017. PMID: 28619508
• Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance.

  Zhuang J, Shen L, Li M, Sun J, Hao J, Li J, Zhu Z, Ge S, Zhang D, Guo H, Huang R, Yan J. Zhuang J, et al. Cancer Res. 2023 May 15;83(10):1611-1627. doi: 10.1158/0008-5472.CAN-22-2213. Cancer Res. 2023. PMID: 36939397
• MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway.

  Tian L, Zhao Z, Xie L, Zhu J. Tian L, et al. Oncotarget. 2017 Dec 20;9(4):4886-4896. doi: 10.18632/oncotarget.23513. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435149 Free PMC article.
• Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.

  Mu L, Yang F, Guo D, Li P, Zhang M. Mu L, et al. Bioengineered. 2020 Dec;11(1):472-483. doi: 10.1080/21655979.2020.1747825. Bioengineered. 2020. PMID: 32250192 Free PMC article.